CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 14, 2017

Total Value ($000): $98,249 (100.0% shares, 0.0% debt)

Holdings (16)

STRONGBRIDGE BIOPHARMA PLC 38.7%
Value ($000) $38,053 Shares 5,514,994 Est. Cost $2.51 Unrealized
SPY SPDR S&P 500 ETF TR 19.7%
Value ($000) $19,358 Shares 77,052 Est. Cost Unrealized
KALA PHARMACEUTICALS INC 12.7%
Value ($000) $12,430 Shares 544,220 Est. Cost $22.84 Unrealized
AGILE THERAPEUTICS INC 8.3%
Value ($000) $8,117 Shares 1,820,012 Est. Cost $6.12 Unrealized
GARRISON CAP INC 7.3%
Value ($000) $7,166 Shares 850,000 Est. Cost $8.52 Unrealized
MOLECULAR TEMPLATES INC 7.2%
Value ($000) $7,066 Shares 1,013,787 Est. Cost $6.97 Unrealized
BRK/B BERKSHIRE HATHAWAY INC DEL 1.7%
Value ($000) $1,640 Shares 8,945 Est. Cost $132.86 Unrealized +33.0%
JBGS JBG SMITH PPTYS 1.3%
Value ($000) $1,236 Shares 36,129 Est. Cost $34.21 Unrealized
INTEC PHARMA LTD JERUSALEM 0.7%
Value ($000) $681 Shares 76,139 Est. Cost $8.94 Unrealized
CM FIN INC 0.6%
Value ($000) $574 Shares 61,429 Est. Cost $9.47 Unrealized
GTX INC DEL 0.5%
Value ($000) $531 Shares 62,869 Est. Cost $8.45 Unrealized
ADNT ADIENT PLC 0.4%
Value ($000) $398 Shares 4,737 Est. Cost $50.50 Unrealized +38.0%
TEAM HEALTH HOLDINGS INC 0.3%
Value ($000) $335 Shares 7,709 Est. Cost $43.46 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 0.3%
Value ($000) $306 Shares 1,997 Est. Cost $130.25 Unrealized +16.1%
ACRS ACLARIS THERAPEUTICS INC 0.3%
Value ($000) $263 Shares 10,176 Est. Cost $25.50 Unrealized +5.1%
MARINUS PHARMACEUTICALS INC 0.1%
Value ($000) $95 Shares 16,198 Est. Cost $5.86 Unrealized